BUY Supriya Lifescience Limited — Deven Mehata, IDBI Capital Markets and Securities
byDeven Mehata, IDBI Capital Markets and SecuritiesHorizon: NA (inferred 1–3 months)24 Jun 2026via NDTV Profit (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·23 Jun · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Supriya Lifescience
- BUY — Kush Bohra29 Sept 2026 · ~2 weeks · target ₹1,020 · SL hit
- BUY — Madhu Bansal29 Sept 2026 · ~2 weeks · target ₹1,078 · SL hit
- BUY — Om Mehra, SAMCO Securities28 Sept 2026 · ~2 weeks · target ₹1,060 · SL hit
- BUY — Dharmesh Shah, ICICI Securities24 Sept 2026 · ~2 weeks · target ₹1,011 · Target hit
- BUY — Om Mehra, SAMCO Securities21 Sept 2026 · ~2 weeks · target ₹980 · Target hit
More from Deven Mehata, IDBI Capital Markets and Securities
- BUY The South Indian Bank21 Oct 2026 · ~2 weeks · target ₹62 · Active
- BUY Ratnaveer Precision Engineering21 Oct 2026 · ~2 weeks · target ₹380 · SL hit
- SELL Shakti Pumps (India)16 Oct 2026 · Same day · target ₹414 · Expired
- BUY Radico Khaitan12 Oct 2026 · ~2 weeks · target ₹4,915 · SL hit
- BUY The South Indian Bank12 Oct 2026 · ~2 weeks · target ₹52 · Target hit

